GTD
Showing 1 - 25 of 28
Hydatidiform Mole Trial in Taft Avenue, Ermita, Manila (Methotrexate, Vitamin B Complex)
Completed
- Hydatidiform Mole
- Methotrexate
- Vitamin B Complex
-
Taft Avenue, Ermita, Manila, Manila, PhilippinesPhilippine General Hospital, University of the Philippines Manil
Apr 16, 2020
COVID, Corona Virus Infection, Adverse Event Trial in New York (EPIC risk score display)
Completed
- COVID
- +2 more
- EPIC risk score display
-
New York, New YorkNYU Langone Health
Dec 22, 2022
Acute Lymphoblastic Leukemia Trial (inotuzumab ozogamicin)
Not yet recruiting
- Acute Lymphoblastic Leukemia
- inotuzumab ozogamicin
- (no location specified)
Jan 6, 2023
Leukemia, Precursor b-Cell Lymphoblastic Leukemia-Lymphoma, ACUTE LYMPHOBLASTIC LEUKEMIA Trial in Worldwide (inotuzumab
Active, not recruiting
- Leukemia
- +2 more
- inotuzumab ozogamicin-dose level 2
- Inotuzumab ozogamicin-dose level 1
-
Los Angeles, California
- +45 more
Mar 9, 2022
Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia Trial in Worldwide (brexucabtagene autoleucel, Cyclophosphamide,
Active, not recruiting
- Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia
- brexucabtagene autoleucel
- +2 more
-
La Jolla, California
- +32 more
Mar 16, 2022
Gestational Trophoblastic Disease, Gestational Trophoblastic Neoplasia, GTD, Recurrent Trial (Pembrolizumab)
Not yet recruiting
- Gestational Trophoblastic Disease
- +2 more
- (no location specified)
Nov 22, 2022
Mantle Cell Lymphoma Trial in United States (bortezomib)
Active, not recruiting
- Mantle Cell Lymphoma
-
San Francisco, California
- +47 more
Aug 16, 2021
Lymphoma, Nonneoplastic Condition Trial in United States (bleomycin sulfate, filgrastim, ABVD regimen)
Completed
- Lymphoma
- Nonneoplastic Condition
- bleomycin sulfate
- +11 more
-
Tucson, Arizona
- +422 more
Aug 16, 2022
Women Diagnosed With Retained Products of Conception
Completed
- Retained Products of Conception
- Plasma B-HCG levels
-
Be'er Ya'aqov, IsraelShamir Medical Center
Jun 7, 2021
Genome Transplant Dynamics: Non-invasive Sequencing-based
Completed
- Cardiac Transplant Rejection
- Lung Transplant Rejection
-
Santa Clara, California
- +1 more
Oct 2, 2019
Acinar Cell Carcinoma, Adenoid Cystic Carcinoma, Adrenal Cortical Carcinoma Trial in Guam, United States (Biospecimen
Recruiting
- Acinar Cell Carcinoma
- +93 more
- Biospecimen Collection
- +2 more
-
Birmingham, Alabama
- +998 more
Aug 23, 2022
Lymphoma, B-Cell Trial in Worldwide (inotuzumab ozogamicin+rituximab +cyclophosphamide+vincristine+prednisone, inotuzumab
Completed
- Lymphoma, B-Cell
- inotuzumab ozogamicin+rituximab +cyclophosphamide+vincristine+prednisone
- inotuzumab ozogamicin+rituximab+gemcitabine+cisplatinum+dexamethasone
-
Gainesville, Florida
- +27 more
Jun 13, 2019
Medical, Emotional and Reproductive Concerns in Gestational
Completed
- Uterine Cancer
- +2 more
- questionnaire
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Apr 27, 2018
Non-Hodgkin's Lymphoma Trial in Spain (Rituximab, Bendamustine, Mitoxantrone, Dexamethasone)
Completed
- Non-Hodgkin's Lymphoma
- Rituximab, Bendamustine, Mitoxantrone, Dexamethasone
-
Santiago, A Coruña, Spain
- +40 more
Feb 21, 2018
Acute Lymphoblastic Leukemia Trial in Worldwide (inotuzumab ozogamicin, FLAG (fludarabine, cytarabine and G-CSF), HIDAC (high
Completed
- Acute Lymphoblastic Leukemia
- inotuzumab ozogamicin
- +3 more
-
La Jolla, California
- +197 more
Dec 20, 2018
Tumor, Trophoblastic, Gestational Trophoblastic Disease, Hydatidiform Mole Trial in Pierre-Bénite
Recruiting
- Neoplasm, Trophoblastic
- +3 more
-
Pierre-Bénite, FranceCentre des Maladies Trophoblastiques Centre Hospitalier Lyon Sud
Sep 2, 2016
Lymphoma, Non-Hodgkin, Lymphoma, Follicular, Lymphoma, Large B-Cell, Diffuse Trial in Worldwide (PF-05082566, rituximab)
Completed
- Lymphoma, Non-Hodgkin
- +6 more
-
Duarte, California
- +41 more
Mar 4, 2020
Rituximab in Combination With Chemotherapy in
Completed
- Lymphoma, Follicular
-
Belgrade, Serbia
- +5 more
Jun 26, 2017
Mantle Cell Lymphoma Trial in Hungary (rituximab [MabThera/Rituxan], First line chemo)
Completed
- Mantle Cell Lymphoma
- rituximab [MabThera/Rituxan]
- First line chemotherapy
-
Budapest, Hungary
- +6 more
Jul 6, 2017
Lymphoma Trial in Worldwide (Inotuzumab Ozogamicin (CMC-544))
Completed
- Lymphoma
- Inotuzumab Ozogamicin (CMC-544)
-
Birmingham, Alabama
- +41 more
Oct 27, 2017
Major Abdominal Surgery, Duodenohemipancreatectomy, Rectal Resection Trial in Ostrava (Flow group, Press group)
Completed
- Major Abdominal Surgery
- +3 more
- Flow group
- Press group
-
Ostrava, Czech RepublicUniversity Hospital Ostrava
Sep 7, 2016
Lymphocytic Leukemia, Chronic, Diffuse Large B-cell Lymphoma, Follicular Lymphoma Trial in Beijing, Guangzhou, Shanghai
Completed
- Lymphocytic Leukemia, Chronic, Diffuse Large B-cell Lymphoma, Follicular Lymphoma
-
Beijing, China
- +3 more
Mar 23, 2016